Upgrade of Chromatography Resin Manufacturing Site in Lanzhou, Empowering Safe, Efficient, and Sustainable Biopharmaceutical Separation and Purification Technology On June 30, 2023, the commissioning ...
CAR-T cell therapy has now become a new choice for tumor patients. Based on the high efficacy of CAR-T cell therapy shown in clinical studies, many front-line medical workers, patients and their families, and investigators in this field are very optimistic about it.
From June 21 to 24, Bio-Link made a stunning appearance with a series of new products at Analytica 2022 (Analytic & Laboratory Equipment Expo) held in Munich Exhibition Center , Germany after continuous R&D and innovation.
After being certified with "ISO 9001:2015", recently, Bio-Link Phas have been certified with "ISO 13485:2016" successfully after a strict and detailed review by the third-party testing and certification body.
This is the second time that Secretary Ding visited the company after one month, which fully shows the high concern and expectation that the Rugao Municipal Committee holds for the development of Bio-Link.
On the afternoon of Aug. 25, Ding Xinghua, Deputy Secretary of Rugao Municipal Committee and Deputy Secretary of the Party Working Committee of Rugao Economic and Technological Development Zone, and his party visited Bio-Link to inspect the construction of the biopharmaceutical single-use consumables manufacturing site.